Among these CRGs, CDKN2A is outstanding for it has high expression in almost all cancer except for esophageal carcinoma (ESCA), while the remaining nine genes have distinct expression patterns in specific cancer types. This evidence concerns the gene CDKN2A and carcinoma of esophagus.